Director, Pediatric Transplantation
BC Children's Hospital
Dr. Tom Blydt-Hansen received his MD, CM from McGill University in 1992. He trained in Pediatrics and Nephrology at the Montreal Children's Hospital, and went on to receive further training in transplantation and research at the University of California, Los Angeles. He started his Nephrology career at the University of Manitoba in 2001 and went on to become Division Head of Nephrology from 2005-2014. Since 2014, he is Director of the Multi-Organ Transplant Program at BC Children’s Hospital and a Senior Scientist at the BC Children’s Hospital Research Institute.
His clinical and translational research program is focused on characterizing kidney allograft injury using urine metabolite profiling and other biomarkers. He is lead investigator in the PROBE study, a CIHR funded multi-center cohort study to identify non-invasive urine biomarkers of allograft rejection in pediatric kidney transplant recipients. Most recently, he received funding from Kidney Foundation of Canada to develop a test for mycophenolate treatment monitoring. He is also engaged in collaborations to identify urinary biomarkers (metabolomics) associated with chronic kidney disease, acute kidney injury, type 2 diabetes and cisplatin nephrotoxicity. He is co-investigator on several nationally funded transplant research studies including CKiD, iCARE, CAN-RESTORE and CNTRP.